Consolidated Planning Corp Has $8.88 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Consolidated Planning Corp lifted its stake in shares of Aflac Incorporated (NYSE:AFL) by 2.4% during the 1st quarter, HoldingsChannel.com reports. The firm owned 79,883 shares of the financial services provider’s stock after buying an additional 1,870 shares during the period. Aflac makes up 1.2% of Consolidated Planning Corp’s investment portfolio, making the stock its 21st biggest position. Consolidated Planning Corp’s holdings in Aflac were worth $8,882,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of AFL. Private Trust Co. NA lifted its position in shares of Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after buying an additional 99 shares during the last quarter. Optas LLC raised its position in Aflac by 3.5% in the first quarter. Optas LLC now owns 2,949 shares of the financial services provider’s stock valued at $328,000 after purchasing an additional 101 shares during the last quarter. Family Legacy Inc. raised its position in Aflac by 4.3% in the fourth quarter. Family Legacy Inc. now owns 2,607 shares of the financial services provider’s stock valued at $270,000 after purchasing an additional 107 shares during the last quarter. Ashton Thomas Private Wealth LLC raised its position in Aflac by 1.9% in the fourth quarter. Ashton Thomas Private Wealth LLC now owns 5,927 shares of the financial services provider’s stock valued at $613,000 after purchasing an additional 110 shares during the last quarter. Finally, Titleist Asset Management LLC raised its position in Aflac by 3.4% in the fourth quarter. Titleist Asset Management LLC now owns 3,324 shares of the financial services provider’s stock valued at $344,000 after purchasing an additional 110 shares during the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Trading Up 0.7%

NYSE AFL opened at $103.31 on Monday. The business has a 50 day simple moving average of $104.91 and a 200 day simple moving average of $105.24. Aflac Incorporated has a one year low of $88.00 and a one year high of $115.50. The stock has a market capitalization of $55.85 billion, a P/E ratio of 16.14, a P/E/G ratio of 3.20 and a beta of 0.82. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.09 and a quick ratio of 0.09.

Aflac (NYSE:AFL) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a return on equity of 15.55% and a net margin of 21.27%. The business had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. During the same period in the prior year, the business earned $1.66 EPS. The company’s revenue for the quarter was down 37.5% on a year-over-year basis. Research analysts expect that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 2nd. Investors of record on Wednesday, May 21st were paid a dividend of $0.58 per share. The ex-dividend date of this dividend was Wednesday, May 21st. This represents a $2.32 annualized dividend and a yield of 2.25%. Aflac’s dividend payout ratio is currently 36.25%.

Insider Buying and Selling

In other Aflac news, Director Masatoshi Koide sold 37,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $105.59, for a total value of $3,906,830.00. Following the completion of the sale, the director now owns 70,992 shares of the company’s stock, valued at approximately $7,496,045.28. This trade represents a 34.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Arthur Reginald Collins sold 2,750 shares of the firm’s stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $105.70, for a total value of $290,675.00. Following the completion of the sale, the director now directly owns 6,728 shares of the company’s stock, valued at $711,149.60. This trade represents a 29.01% decrease in their position. The disclosure for this sale can be found here. Insiders sold 40,750 shares of company stock valued at $4,304,295 over the last 90 days. Company insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have commented on the company. Wall Street Zen downgraded Aflac from a “hold” rating to a “sell” rating in a research report on Monday, May 5th. Barclays increased their target price on Aflac from $95.00 to $96.00 and gave the company an “underweight” rating in a research report on Thursday, May 1st. Keefe, Bruyette & Woods increased their target price on Aflac from $104.00 to $106.00 and gave the company a “market perform” rating in a research report on Wednesday, May 7th. Wells Fargo & Company raised their price objective on Aflac from $102.00 to $103.00 and gave the stock an “equal weight” rating in a research report on Tuesday, May 6th. Finally, Piper Sandler raised their price objective on Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 2nd. Three analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $104.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.